Trial intelligence / Profile preview

Cholecalciferol Supplementation in Hemodialysis Patients with Vitamin D Deficiency

NCT03648528Phase 4Completed

Sponsor
CASMU
Start
Oct 2015
Primary completion
May 2018
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

A Phase 4 trial of vitamin d in Vitamin D deficiency (VDD), secondary hyperparathyroidism (SHPT), sponsored by CASMU. Started Oct 2015; status: completed.

02

Drugs

vitamin d
03

Conditions

Vitamin D deficiency (VDD)secondary hyperparathyroidism (SHPT)

Beyond the preview

Go deeper on NCT03648528.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03648528.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call